Given previous research indicating that c‐MYC could suppress tumor immunogenicity and promote immune evasion,[38] we further verified that I3A treatment significantly reduced c‐Myc gene expression by q‐PCR (Figure 6C). This evidence concerns the gene MYC and neoplasm.